CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 12 enrolled
Drug / intervention
Isotopically labeled lycopene, phytoene or phytoflueneother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01692340
NCT01692340Phase 2Completed

Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans.

Ohio State University Comprehensive Cancer Center·interventional·Posted Sep 25, 2012·Updated Mar 26, 2019

In Brief

A Phase 2 clinical trial evaluating Isotopically labeled lycopene, phytoene or phytofluene for Healthy. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Tomatoes contain several compounds which may be beneficial for human health and prevention of disease, although this relationship is poorly understood and very controversial. This study uses a new technology to study the absorption and metabolism of three different compounds found in tomatoes. These compounds are called: phytoene, phytofluene, and lycopene. We hypothesize that by studying the absorption and metabolism of these compounds, we may be able to understand how the compounds may influence health and disease processes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 25, 2012
Enrollment StartFeb 1, 2012
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.8 years ago

Interventions

Isotopically labeled lycopene, phytoene or phytoflueneother

We will administer 10 mg of labeled carotenoid mixed with olive oil and spread on an English muffin for consumption by participants.